scholarly journals Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion

Author(s):  
Scott Turner ◽  
Jason Voogt ◽  
Michael Davidson ◽  
Alex Glass ◽  
Salena Killion ◽  
...  
Author(s):  
Naomi C Bernecic ◽  
Simon P Graaf ◽  
Tamara Leahy ◽  
Bart M Gadella

ABSTRACT Reverse Cholesterol Transport or cholesterol efflux is part of an extensive plasma membrane remodelling process in spermatozoa that is imperative for fertilisation. For ram spermatozoa, sheep serum is well known to support in vitro fertilisation (IVF), but knowledge of its explicit role is limited. Though, it is postulated to elicit cholesterol efflux owing to the presence of high density lipoproteins (HDLs) that interact with transmembrane cholesterol transporters, such as ATP-binding cassette transporter A1 (ABCA1) and scavenger receptor class B, type I (SR-BI). In this study, we report that both sheep serum and HDLs were able to elicit cholesterol efflux alone by up to 20–40% (as measured by the BODIPY-cholesterol assay). Furthermore, when the antagonists glibenclamide and valspodar were used to inhibit the function of ABCA1 and SR-BI or ABCA1 alone, respectively, cholesterol efflux was only marginally reduced (8–15)%. Nevertheless, it is likely that in ram spermatozoa, a specific facilitated pathway of cholesterol efflux is involved in the interaction between cholesterol acceptors and transporters. Interestingly, exposure to HDLs also induced hyperactivated motility, another critical event required for successful fertilisation. Taken together, this study details the first report of the dual action of HDLs on ram spermatozoa, providing both an insight into the intricacy of events leading up to fertilisation in vivo as well as demonstrating the possible application of HDL supplementation in media for IVF.


2015 ◽  
Vol 35 (suppl_1) ◽  
Author(s):  
Souade Ikhlef ◽  
Hicham Berrougui ◽  
Abdelouahed Khalil

Paraoxonase 1 (PON1) is a High Density Lipoprotein (HDL) associated enzyme which contributes to the antioxidant and anti-inflammatory properties of HDL. It also stimulates cholesterol efflux mediated by HDL. The purpose of this study is to determine the mechanism by which PON1 regulates this antiatherogenic activity of HDL. The oxidized phospholipids hydrolysis by PON1 results in the formation of Lysophosphatidylcholine (LPC). The phospholipase PON1 activity effect on the cholesterol efflux and the gene and protein expression were determined in vitro on J774 macrophages cells and was also determined in vivo on C57/BL6 male mice. Our results show that due to its phospholipase activity, PON1 hydrolyzes oxidized LDL (oxLDL) and contributes to the formation of LPC, which stimulates cholesterol efflux from macrophages. Our results show that PON1 induced the expression of ABCA1 cholesterol transporters. Western blot as well as qPCR analysis show that PON1 stimulate PPARγ and LXRα nuclear receptors expression. Moreover, the use of ABCA1, PPARγ and LXRα inhibitors (respectively DIDS, GGPP and GW9662) affects the capacity of PON1 to stimulate cholesterol efflux, in particular by decreasing the proteins expression of interest (ABCA1, PPARγ and LXRα). Incubation of macrophages with purified LPC with macrophages induces a high expression of PPARγ-LXRα-ABCA1 pathway. Incubation of macrophages with PON1-oxLDL mixture and their injection to mice increase significantly the reverse cholesterol transport. Our results show that tPON1 stimulate both cholesterol efflux and RCT. via the regulation of the PPARγ-LXRα-ABCA1 pathway. This effect is attributed to the phospholipase activity of PON1 which mediates the hydrolysis of ox-LDL to form LPC.


Biomedicines ◽  
2020 ◽  
Vol 8 (8) ◽  
pp. 266
Author(s):  
Lídia Cedó ◽  
Sara Fernández-Castillejo ◽  
Laura Rubió ◽  
Jari Metso ◽  
David Santos ◽  
...  

The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo.


1993 ◽  
Vol 23 (2) ◽  
pp. 122-129 ◽  
Author(s):  
M. CASTRO CABEZAS ◽  
G. P. H. VAN HEUSDEN ◽  
T. W. A. DE BRUIN ◽  
J. R. C. M. VAN BECKHOVEN ◽  
L. A. W. KOCK ◽  
...  

Nutrients ◽  
2018 ◽  
Vol 10 (12) ◽  
pp. 1885
Author(s):  
Daniela Greco ◽  
Simone Battista ◽  
Laura Mele ◽  
Antonio Piemontese ◽  
Bianca Papotti ◽  
...  

It has been well established that moderate alcohol consumption inversely correlates with cardiovascular morbidity and mortality, whereas binge alcohol drinking increases cardiovascular disease risk. The aim of this study was to assess in vivo the impact of different drinking patterns on reverse cholesterol transport (RCT); the atheroprotective process leading to the removal of excess cholesterol from the body. RCT was measured with a standardized, radioisotope-based technique in three groups of atherosclerosis-prone apolipoprotein E knock out mice: Placebo group, receiving water, which would mimic the abstainers; moderate group, receiving 0.8 g/kg alcohol/day for 28 days, which would mimic a moderate intake; binge group, receiving 0.8 g/kg alcohol/day for 5 days/week, followed by the administration of 2.8 g/kg alcohol/day for 2 days/week, which would mimic a heavy intake in a short period. Mice in the binge drinking group displayed an increase in total cholesterol, high density lipoprotein cholesterol (HDL-c) and non-HDL-c (all p < 0.0001 vs. placebo), and a significantly reduced elimination of fecal cholesterol. The moderate consumption did not lead to any changes in circulating lipids, but slightly improved cholesterol mobilization along the RCT pathway. Overall, our data confirm the importance of considering not only the total amount, but also the different consumption patterns to define the impact of alcohol on cardiovascular risk.


Sign in / Sign up

Export Citation Format

Share Document